Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Biomarker Discovery & Development | Webinars

Breath Biopsy Omni For Comprehensive & Reliable Detection Of VOC Biomarkers In Breath

29 November 2022
On-Demand Webinar featuring Dr Elizabeth Crone, Business Development Manager at Owlstone & Dr Hsuan (Tina) Chou, Biomarker Scientist at Owlstone

Non-invasive biomarkers are of great interest for use in disease screening and ongoing health monitoring. Researchers and clinicians seeking reliable, non-invasive methods for biomarker discovery, including both untargeted and focused approaches, should join this webinar.

The presentation will cover applications of non-invasive biomarkers for early detection of disease and precision medicine. Owlstone Medical’s Breath Biopsy️ is suited to the collection and analysis of breath samples across a range of therapeutic areas including respiratory and inflammatory diseases, oncology, and liver disease. This webinar will present case studies from these areas and Owlstone Medical’s approach to developing biomarker solutions.

https://youtu.be/qrxccrM8iGE

Speaker Biographies

Dr Elizabeth Crone

Liz is a Business Development Manager in Owlstone focussing on Europe and Asia. She has a scientific background in biomolecular analytics, with a PhD from the University of Cambridge looking at protein stability in conditions of oxidative stress. She has spent the last decade working for companies who have novel and interesting technologies and ideas - she specialises in helping to connect that science up with researchers who could benefit from using it.

 

Dr Hsuan (Tina) Chou

Tina Chou joined Owlstone in Sept. 2021 as a biomarker scientist where she is involved in helping customer study design, biological result interpretation and final report delivery. She is also involved in some of the internal R&D projects that revolve around improving the platform for breath analysis.

Related Resources

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Read More

Abcam: Keep your research moving with our tools

Read More

Unlock access to the latest research insights

Read More